Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B
Background & aims. A novel controlled attenuation parameter (CAP) using the signals acquired by the FibroScan® has been developed as a method for evaluating steatosis. The aim of this study is to assess the performance of the CAP for the detection and quantification of steatosis in patients...
| Glavni autori: | , , , , , , , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
Elsevier
2015-11-01
|
| Serija: | Annals of Hepatology |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S1665268119309512 |